Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Clin J Pain. 2019 May;35(5):407–419. doi: 10.1097/AJP.0000000000000695

Table 3.

Transparent Reporting of Trials

Event # Controls # FMS patients
Screened*: 22 23
Did not meet inclusion criteria: 7 7
Declined to participate: 2 2
Exposed to first temperature: 13 14
(At random either 24 or 19°C)
Discontinued study: 2 1
Exposed to second temperature: 11 13
(At random either 24 or 19°C)
* Screening questions by phone for eligibility for further assessment:
 Gender F
 Age 18–55
 Premenopausal yes
 Pregnant No
 FMS Yes or No
 Medications No
 Able to comply with study procedures Yes
 Serious medical condition other than FMS No